TFS News Briefs: 10/21/07

Posted October 21st, 2007 at 12:23 PM by Jimmie R. Markham

Section: News & Results, Marathons, Cross Country, Olympics, Drugs In Sports, TFS News Briefs

TFS News Briefs
Kinyanjui Runs 3-Minute PB in Beijing Marathon
Kenyan Nephat Kinyanjui bested his previous PB of 2:11:18 by over three minutes in winning the 2007 Bejing Marathon in 2:08:09. Nineteen-year-old Chen Rong won the women’s race in 2:27:05. Read more at: [IAAF]

Kalovics Defends 2006 Win with 2:28:17 Victory in Carpi Marathon
Hungarian Aniko Kalovics, even though she was slowed a bit by problems with her Achilles tendon and with tonsilitis still managed to win her 2nd Carpi Marathon in 2 years with a 2:28:17 win. Kenyan Noah Serem led the men with a PB 2:11:18. Read more at: [IAAF]

Oregon Men and Women Win Team Titles at Beaver Classic
The University of Oregon men’s cross-country team, the #1 ranked team in the nation according to the USTFCCCA poll, took the team title at the Beaver Classic with a near-perfect 16 points. The women Ducks also won the team title, scoring a perfect 15 points.
Read more at: [GoDucks.com]

Preview of US Olympic Trials Marathon Men’s Race
TheDay.com has a preview of the US Olympic Trials Marathon Men’s Race, including an interesting bit of information: spectators can see the men run by as many as 10 times during the course which is a loop course. Read more at: [TheDay.com]

DEA Drug Sting Will Name Names “At Every Level”
A DEA crackdown of steroids called Operation Raw Deal that has recovered over 11 million doses of drugs from over 50 labs. In a recent meeting, USOC chairman Peter Ueberroth suggested a “more draconian penalty structure.” Read more at: [USA Today]

***Note: We encourage EVERYONE to see a doctor before altering their diet, taking a supplement and/or performing athletic, fitness or other strenuous physical activity. It is your responsibility to evaluate the accuracy, completeness and usefulness of any information, instruction, opinion or advice contained in the content. Please also see our complete disclaimer.***

Comment on this post | Permalink